However, it is clearly shown that abnormal levels of KP metabolites, especially Kyn and Kyna, during neurodevelopment have been related to several neurobiochemical and behavioral impairments associated with depression, anxiety, ASD, and SCZ phenotypes (Figure 2). The gene discussed is NPPA; the disease is depressive disorder.